ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2208

A Novel Omeract MRI Scoring System Providing Insights in the Association of MRI Synovitis and Bone Marrow Lesions with Pain in Thumb Base Osteoarthritis

F.P.B. Kroon1, S. van Beest1, W. Damman1, R. Liu1, J.L. Bloem2, M. Reijnierse2 and M. Kloppenburg1,3, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Radiology, Leiden University Medical Center, Leiden, Netherlands, 3Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Hand disorders, MRI, Osteoarthritis, pain and synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Osteoarthritis – Clinical Aspects Poster II: Observational and Epidemiological Studies

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoarthritis (OA) in the thumb base joints (first carpometacarpal [CMC1] and scaphotrapeziotrapezoid [STT]) is highly prevalent and disabling, however much is still unknown about its pathophysiology, and focussed studies on thumb base OA are rarely performed. We took advantage of the newly developed OMERACT thumb base OA MRI scoring system (TOMS)1 to investigate the prevalence of MRI synovitis and bone marrow lesions (BMLs) in the thumb base, and their association with pain, in addition to radiographic features.

Methods: Two readers scored MRIs of the right thumb base for synovitis and BMLs in CMC1 and STT (grade 0-3) in consecutive patients diagnosed by their treating rheumatologist with primary hand OA from the Hand OSTeoArthritis in Secondary care (HOSTAS) study. BMLs were evaluated in proximal and distal joint parts separately, resulting in 0-6 and 0-9 sum scores for CMC1 and STT, respectively. Synovitis and BML scores were both aggregated into dichotomous thumb base scores (0-1 in both joints versus ≥2 in at least one joint). Trained nurses assessed thumb base tenderness on palpation. Osteophyte presence (according to OARSI atlas) in CMC1 and STT was assessed on radiographs. Associations between MRI synovitis or BMLs and thumb base tenderness were analysed using logistic regression, stratified for absence/presence of osteophytes.

Results: 85 of 202 hand OA patients (84% women, mean age 60.1 years, 90% fulfilling ACR criteria) reported thumb base tenderness on palpation. Synovitis was seen in both thumb base joints (CMC1 42%, STT 37%), although prevalence of grade 2-3 synovitis was low in both the CMC1 (16%) and STT (14%). BMLs were present in CMC1 and STT in 54 and 53%, respectively, with 18 and 21% having a sum score of 2-3, and 16 and 7% a sum score ≥4. In absence of radiographic osteophytes, presence of synovitis or BMLs in either thumb base joint was not statistically significantly associated with thumb base tenderness (odds ratio (OR) 1.9 [95% confidence interval 0.6-6.4] and 1.5 [0.5-4.3]). However, in absence of severe synovitis or BMLs, radiographic osteophytes and pain were associated, with increasing ORs when synovitis or BMLs were additionally present (Table). Similar results were found for self-reported thumb base pain (not shown).

 

Conclusion: Synovitis and BMLs are present in thumb base OA, although severe synovitis or BMLs were uncommon. Osteophytes seemed more important in predicting thumb base tenderness than synovitis or BMLs alone. Combined presence of osteophytes and synovitis or BMLs had a small additive effect. These findings differ from interphalangeal OA studies, supporting thumb base OA as a distinct subset. It might also explain why trials investigating intra-articular corticosteroids in thumb base OA produced equivocal results.

1Kroon F, et al. J Rheumatol 2017;44:pii.[epub ahead of print].

 

Table. Associations (odds ratios with 95% confidence intervals) of MRI synovitis or BMLs and radiographic osteophytes with pain on palpation in thumb base osteoarthritis (n=196*)

 

 

Osteophyte CMC-1 or STT

 

 

Absent

n=106

Present

n=90

   Synovitis

CMC1 and STT grade 0-1

n=145

1

n=93

4.2 (2.0-8.6)

n=52

CMC1 or STT grade ≥ 2

n=51

1.9 (0.6-6.4)

n=13

5.9 (2.6-13.3)

n=38

   BML

CMC1 and STT grade 0-1

n=109

1

n=85

4.3 (1.7-11.0)

n=24

CMC1 or STT grade ≥ 2

n=87

1.5 (0.5-4.3)

n=21

5.3 (2.6-10.8)

n=66

BML, bone marrow lesion; CMC1, first carpometacarpal; MRI, magnetic resonance imaging; STT, scaphotrapeziotrapezoid.

*n=196 patients with available radiographs and evaluable MRI for synovitis and BMLs.

 


Disclosure: F. P. B. Kroon, Dutch Arthritis Fund, 2; S. van Beest, Dutch Arthritis Fund, 2,IMI APPROACH, 2; W. Damman, Dutch Arthritis Fund, 2; R. Liu, Dutch Arthritis Fund, 2; J. L. Bloem, None; M. Reijnierse, None; M. Kloppenburg, Pfizer, 2,AbbVie, GlaxoSmithKline, Merck, Levicept, 5,Dutch Arthritis Fund, 2.

To cite this abstract in AMA style:

Kroon FPB, van Beest S, Damman W, Liu R, Bloem JL, Reijnierse M, Kloppenburg M. A Novel Omeract MRI Scoring System Providing Insights in the Association of MRI Synovitis and Bone Marrow Lesions with Pain in Thumb Base Osteoarthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/a-novel-omeract-mri-scoring-system-providing-insights-in-the-association-of-mri-synovitis-and-bone-marrow-lesions-with-pain-in-thumb-base-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-novel-omeract-mri-scoring-system-providing-insights-in-the-association-of-mri-synovitis-and-bone-marrow-lesions-with-pain-in-thumb-base-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology